Hepatitis Drug Development Pipeline Review, 2017; New Report Launched
Hepatitis Drug Development Pipeline Review, 2017 report provides an overview of the hepatitis pipeline landscape. The report provides comprehensive information on the therapeutics under development and key players involved in therapeutic development for hepatitis A, B, C and D, and features dormant and discontinued projects.
View full press release